Hong Kong vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Sur
82.0%
in 2024
Hong Kong rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Sur
How they compare
Hong Kong currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Hong Kong's figure about 1.2 times Sur's.
The two have swapped places 2 times across 15 shared years of data; in 2003 it was Hong Kong ahead.
Hong Kong ranks 1st and Sur ranks 2nd of 144 countries.
Across the 3 decades both report, Hong Kong averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Hong Kong | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.2% | 27.5% | 25.8% | Hong Kong |
| 2010s | 31.1% | 66.5% | 35.4% | Sur |
| 2020s | 92.2% | 75.8% | 16.4% | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Sur?
- Hong Kong, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Sur?
- 18.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Sur?
- 15 years are reported by both, from 2003 to 2024.
- How do Hong Kong and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.